Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Contineum Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Harmony Biosciences Holdings Inc. May 14, 202670.6%
-
Contineum Therapeutics Inc. June 26, 202599.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +5,500 | $26.10 | $143,550 |
| Mar 13, 2025 | Rapport Therapeutics Inc. | Open-market purchase | +100 | $9.98 | $998 |
| Mar 12, 2025 | Rapport Therapeutics Inc. | Open-market purchase | +9,900 | $10.10 | $99,990 |
Questions about Troy A. Ignelzi
What boards is Troy A. Ignelzi on?
Troy A. Ignelzi sits on the boards of Contineum Therapeutics Inc. and Harmony Biosciences Holdings Inc.
How long has Troy A. Ignelzi served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.